RedHill Biopharma Announces Definitive Agreement for Up To $6 Million Private Placement with a Single Investor

TEL AVIV, Israel and RALEIGH, NC, March 8, 2023 /PRNewswire/ — RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced agreement, with a single investor, for the issuance of convertible promissory note in the principal…

Leave a Reply

Your email address will not be published. Required fields are marked *